Xiaoping Zhou
Impact in
-
- Immune cells in cancer
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 8
- Cancer Cells and Metastasis 3
- Cancer-related Molecular Pathways 2
-
- PI3K/AKT/mTOR signaling in cancer 3
- Co-authors
- Dongbo Li (3 shared papers)Han Zhang (3 shared papers)Hongfei Ji (6 shared papers)Jinlu Wang (4 shared papers)Qingyuan Zhang (4 shared papers)Lei Yin (4 shared papers)Ziwen Zhang (2 shared papers)Xingjian Niu (5 shared papers)
- Journals
- Cancer Science (2 papers)European Journal of Medicinal Chemistry (2 papers)Journal of Cancer (2 papers)Anti-Cancer Agents in Medicinal Chemistry (1 paper)Molecules (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaoping Zhou
34 papers receiving 899 citations
Peers
Comparison fields: 5 of 84
- Immunology 206
- Oncology 239
- Cancer Research 129
- Molecular Biology 529
- Pathology and Forensic Medicine 79
Countries citing papers authored by Xiaoping Zhou
This map shows the geographic impact of Xiaoping Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Zhou more than expected).
Fields of papers citing papers by Xiaoping Zhou
This network shows the impact of papers produced by Xiaoping Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Zhou. The network helps show where Xiaoping Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 194 | |
| 2 | 2002 | 156 | |
| 3 | 2021 | 156 | |
| 4 | 2002 | 67 | |
| 5 | 2021 | 60 | |
| 6 | 2020 | 47 | |
| 7 | 2019 | 27 | |
| 8 | 2019 | 27 | |
| 9 | 2019 | 21 | |
| 10 | 2021 | 19 | |
| 11 | 2021 | 16 | |
| 12 | 2015 | 13 | |
| 13 | 2017 | 13 | |
| 14 | 2009 | 12 | |
| 15 | 2021 | 11 | |
| 16 | 2011 | 9 | |
| 17 | 2015 | 9 | |
| 18 | 2016 | 8 | |
| 19 | 2019 | 8 | |
| 20 | 2016 | 7 |
About Xiaoping Zhou
Xiaoping Zhou is a scholar working on Oncology, Molecular Biology, Pharmacology, Organic Chemistry and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 919 indexed citations. Recurring topics across this work include Synthesis of Organic Compounds (3 papers), Cancer Cells and Metastasis (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Axial and Atropisomeric Chirality Synthesis (3 papers), Cancer-related Molecular Pathways (2 papers), Crystal structures of chemical compounds (2 papers), Ferroptosis and cancer prognosis (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Immunology (206 citations), Oncology (239 citations), Cancer Research (129 citations), Molecular Biology (529 citations) and Pathology and Forensic Medicine (79 citations). Xiaoping Zhou has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Dongbo Li, Han Zhang, Hongfei Ji, Jinlu Wang, Qingyuan Zhang, Lei Yin, Ziwen Zhang, Xingjian Niu, Charis Eng and Yucui Gu. Their work appears in journals such as Cancer Science, European Journal of Medicinal Chemistry, Journal of Cancer, Anti-Cancer Agents in Medicinal Chemistry and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.